Details

Autor(en) / Beteiligte

• Abbassi, Nadia
• Bourrahouat, Aicha
• Bedoya, Eduardo Couchonnal
• Pagan, Cécile
• Qabli, Meriem El
• Maidoumi, Sana
• Belmalih, Abdelouahed
• Guillaud, Olivier
• Kissani, Najib
• Abkari, Abdelhak
• Chahid, Imane
• Rafai, Mohammed Abdoh
• Mouane, Nezha
• Kriouile, Yamna
• Aidi, Saadia
• Hida, Moustpha
• Idrissi, Mounia Lakhdar
• Belahsen, Mohammed Faouzi
• Abkari, Mohammed El
• Rkain, Maria
• Ismaili, Zahi
• Sedki, Azeddine
• Bost, Muriel
• Aboussair, Nisrine
• Lachaux, Alain

Titel

Phenotype and molecular characterization of Wilson's disease in Morocco

Ist Teil von

• Clinics and research in hepatology and gastroenterology, 2024-05, Vol.48 (5), p.102335-102335, Article 102335

Ort / Verlag

France: Elsevier Masson SAS

Erscheinungsjahr

2024

Quelle

Elsevier ScienceDirect Journals

Beschreibungen/Notizen

• •The present study is the first population-based epidemiological study on WD in the Maghreb, estimating the prevalence and addressing all aspects of WD: epidemiology, clinical forms, diagnosis, genetic analysis, treatment and mortality rate.•The prevalence of WD was higher in Moroccan population.•The mortality was higher in Moroccan patients with WD and patients died at an early age.•These data can help better understand this disease burden and improve the diagnosis. In Morocco the prevalence of Wilson disease (WD) and the spectrum of mutations are not known. The aim of the present study was to estimate the prevalence of WD in Morocco, to evaluate the phenotype among a large cohort of WD patients, and to characterize ATP7B variants in a subgroup of WD patients. We collected data from 226 patients admitted to five university hospital centers in Morocco between 2008 and 2020. The diagnosis was based on clinical manifestations, function tests and biochemical parameters. The genotype was characterized in 18 families diagnosed at the University Hospital Center of Marrakesh, by next generation sequencing. The mean annual prevalence in Morocco was 3.88 per 100,000 and the allele frequency was 0.15 %. Among the 226 patients included (121 males and 105 females), 196 were referred for a hepatic or neurological involvement and 30 were asymptomatic. The mean age at diagnosis was 13 ± 5.1 years (range: 5 - 42 years). Consanguinity was found in 63.3 % of patients. The mean duration of illness was 2.8 ± 1.9 years. Kayser-Fleischer rings were found in 131 (67.9 %) of 193 patients. Among the 196 symptomatic patients, 141/159 (88.7 %) had low serum ceruloplasmin (<0.2 g/L) and a high 24-hours urinary copper (>100 μg/day) was found in 173/182 (95.1 %) patients. The initial treatment was D-penicillamine in 207 patients, zinc acetate in five, zinc sulfate in five, and nine patients were not treated; 60/207 (29 %) patients have stopped treatment. A total of 72 patients died; the mortality rate was 31.9 %. Eight different ATP7B variants were identified among the 18 patients studied, of which two were novel (p.Cys1104Arg and p.Gln1277Hisfs*52), and six previously published (p.Gln289Ter, p.Cys305Ter, p.Thr1232Pro, p.Lys1020Arg, p.Glu583ArgfsTer25 and c.51+4A>T). All informative patients were homozygous for the disease-causing mutation. In Morocco, a high prevalence due to consanguinity and a high mortality rate due to the difficulty of diagnosis and lack of treatment were observed in WD patients. NGS sequencing identified new ATP7B variants in WD patients from Morocco.